Pablo J. Cagnoni - Dec 31, 2021 Form 5 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role
CEO and President, Director
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Stock symbol
RUBY
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/14/2022, 06:52 PM
Previous filing
Jun 7, 2021
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RUBY Common Stock Gift $0 -4K -11.26% $0.00 31.5K Apr 26, 2021 Direct
transaction RUBY Common Stock Gift $0 -2.2K -6.98% $0.00 29.3K Jun 16, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.